Cao Sean Wuxiong bought NBP
June 22, 2026 · Form 4 insider transaction
Cao Sean Wuxiong bought 181,280 shares of NovaBridge Biosciences at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 2 days after the transaction.
Direction
Acquired (buy-side)
Shares
181,280
Price
$0.00
Total value
N/A
InsiderCao Sean Wuxiong
RoleOfficer, Director
CompanyNovaBridge Biosciences (NBP)
SecurityRestricted Share Units
Transaction codeA: Grant or award
Transaction dateJune 22, 2026
Filing dateJune 24, 2026
Shares owned after181,280
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
Each restricted stock unit ("RSU") represents a contingent right to receive one American Depositary Shares ("ADS").; Number of underlying securities and exercise price expressed in terms of ADSs.; The RSUs shall vest over four years, with one-fourth vesting on September 3, 2026 and the balance vesting ratably over the subsequent 12 quarters on the third day of each third month.; The Ordinary Shares may be represented by ADSs. Each 10 ADSs represent 23 Ordinary Shares of the Issuer.